Rarely, individuals carrying a homozygous deletion of SMN1 and three or four SMN2 copies are fully asymptomatic, in contrast to approximately 99% of individuals with such a genotype who develop SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.